STOCKS CLIMB AS HUGE WEEK ON WALL STREET KICKS OFF

Consumer expectations in the U.S. for stocks hit 3-year high in May

PRTA Jan 2026 25.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

8.90

0.00

(0.00%)

As of 09:58AM EDT. Market open.

Loading interactive chart...

Zacks
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
FDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of Alzheimer's drug Leqembi. The final FDA decision is expected on Jan 25, 2025.
Zacks
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.